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Abstract 
 
Histone Nuclear Factor-P (HiNF-P) is the final link in a CyclinE/CDK2à  
p220NPAT pathway to cell cycle-dependent transcription of histone H4.  In this project, 
mutations were introduced to HiNF-P to study the biological effects of the P-Specific 
Conserved Region (PSCR), a highly conserved region whose specific activity is unknown. 
Assays were carried out to quantify expression (Western), subcellular localization 
(immunofluorescence), DNA binding (EMSA), and H4 promoter activity (luciferase).  
The data strongly suggest that the first twenty amino acids of the PSCR are essential for 
DNA binding. 
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Background 
 
 
For decades an understanding of the process by which cells divide and proliferate 
has been highly sought after but even with decades of research, still much is not 
understood.  Eukaryotic cells go though a highly regulated cell cycle in order to divide.  
This process consists of four steps: G1, S (synthesis), G2, and M (mitosis), each 
describing key events of the cell during this time period (Figure 1).  There are also 
checkpoints at the end of each stage that make sure the cell does not progress to the next 
stage until it is ready to do so (Alberts et al., 2002).  Of particular interest is the junction 
where the cell moves from a state of development in preparation for division, G1, to the 
synthesis of new DNA, S phase.  This point, known as the G1/S transition, is where 
replication-dependent histones are produced.  
 
Figure 1. The Eukaryotic Cell Cycle (Alberts et al., 2002). 
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Histones and DNA Packaging 
 
 Histones have a very special task to package up the lengthy DNA into small 
compact nucleosomes.  Their impressive ability to accomplish this is highlighted by the 
fact that histones effect an approximate compression ratio of 1000-fold on the DNA 
(Alberts et al., 2002).  The five histones H1, H2A, H2B, H3, and H4 all take part in 
creating the nucleosome.  Two molecules of H2A, H2B, H3, and H4 form the histone 
octamer, around which the double stranded DNA is wound.  These histones are also 
referred to as the core histone proteins.  To form the histone octamer, H3 and H4, along 
with H2A and H2B form dimers with each other.  The H3 - H4 dimers form a tetramer, 
and the two H2A-H2B dimers form around the tetramer completing the histone octamer.   
Once the DNA is wound around the octamer, a final histone H1 is added to the 
nucleosome, binding the histone core proteins and DNA, helping to compact the structure 
(Alberts et al., 2002).  Figure 2 shows this chromatin packaging process, which 
eventually ends with the final compact genetic infrastructure, the chromosome.  
Control of Histone Synthesis 
 
Not only are the histone proteins themselves vital, but the multiple synchronized 
processes that regulate histone synthesis are of the utmost importance, as it has been 
shown that unbalanced levels of histone proteins can cause loss of chromosomes (Meeks-
Wagner & Hartwell, 1986). Histones have a very specific and important function, which 
is needed when new DNA is being synthesized. Though variants of histones are produced 
at basal levels throughout the cell cycle, 90% are replication-dependent and transcribed 
during S phase.  The production of histone mRNA is controlled by three pathways (Wu 
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and Bonner, 1981).   The first level of histone transcriptional control is at the G1/S 
transition.  Here, histone mRNA synthesis is increased three to five fold over the 
preceding G1 stage (Reviewed in Osley, 1991).   The remaining five to six fold additional 
histone mRNA increase is accounted for at the posttranscriptional level.   
 
Figure 2. Structural Overview of the Genome.  Double stranded DNA is wound around the histone core 
proteins to create the nucleosome.  Multiple nucleosomes are further compacted into chromatin, which 
makes up the chromosome. (National Institutes of Health) 
 
The first posttranscriptional pathway causes an increase in the histone mRNA half 
life.  The half life of histone mRNA when chromosome replication is blocked has been 
experimentally estimated to be between 10 to 15 minutes.  During S phase, however, the 
histone mRNA half life increases to 30 to 60 minutes (Reviewed in Osley, 1991).  This 
enables the already increasing amounts of histone mRNA to last for a longer duration.  
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The second posttranscriptional pathway deals with the processing of histone pre-mRNAs.  
Before histones can become mature and functional cytoplasmic mRNAs, their 3 ends 
must be processed by endonucleases.  Harris et al. (1991) showed that increased 3 
processing leads to a six to eight fold increase in histone mRNA levels (Reviewed in 
Osley, 1991).  These three regulatory mechanisms account for the large induction of 
histones at a crucial time when these specific proteins are needed the most. 
 
Histone H4/n Gene as a Model for Histone Behavior 
 
In order to study the effects of HiNF-P on histone function, the selection of a 
model gene and analogous protein was necessary. Because histone H4 is the most highly 
conserved protein in the nucleus, it was the ideal candidate to select as a model histone.  
The corresponding mRNA transcript was also well characterized making it appropriate to 
study cell cycle related effects (Mitra et al., 2003; Braastad et al., 2004).  To ensure 
consistency in experimental results, the H4/n subtype was selected as the model gene, 
which which HiNF-P would be tested.  Though the amino acid sequences of all histones 
are highly conserved because of the essential role histones play in DNA packaging, H4 is 
the most conserved compared with all histone proteins (Alberts et al., 2002; Mitra et al., 
2003).  
Site II (Figure 3) plays an important role in the histone H4/n gene. The histone 
H4/n gene contains two protein binding sites within the proximal promoter; Site I is 
located from nt -150 to -113, and Site II located from nt -97 to -47 (Pauli, et al., 1987; 
Van Wijnen, et al., 1992).  Site II contains a highly conserved nucleotide sequence 
unique to the many of H4 genes located in the human genome.  This sequence contains 
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many G residues necessary for DNA-protein interactions (Mitra et al., 2003).  Studies 
have shown that there are several histone nuclear binding factors (HiNFs) that have the 
ability to bind to Site II, named HiNF-D, HiNF-M, and HiNFP (van Wijnen et al., 1991). 
 
Figure 3. HiNF-P binds to Site II of the H4/n Proximal Promoter.   While there are other proteins  that 
interact with Site I and Site II this figure only shows HiNF-P for clarity. 
  Adapted from van Wijnen et al. (1992). 
 
 
Activation of Histone H4/n via the Cyclin-E Pathway 
 
 The signaling pathway that allows cells to progress into the S phase is ultimately 
linked to the cells ability to synthesize functional histones. When cells are ready to begin 
proliferation, they initiate a signal cascade beginning with growth factors which activates  
a master transcription factor E2F.  E2F is one of the most highly studied transcription 
factors because it has such a global effect on how cells progress though the cell cycle.  It 
is responsible for the transcription of many proteins required for progression into S phase 
(Stevens and Thangue, 2003).  Even though E2F is known to activate G1/S specific genes, 
it can not directly activate histone H4/n because the cell cycle regulatory site II lacks well 
known and widely accepted E2F binding sites (van Wijnen et al., 1991 and Stevens and 
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Thangue).  This means E2F must initiate a signal cascade in which other downstream 
messengers activate histone transcription (Figure-4).  These downstream messengers 
have been characterized by many researchers, and are described in detail below.  
 
 
Figure 4. Overview of the Cyclin E/CDK2/p220NPAT/ HiNF-P Pathway for Activating Histone H4.  
Adapted from Stein et al. (2006). 
 
 
Cyclin E 
 
One of the initial downstream targets of E2F is cyclin E. Cyclin E is sometimes 
referred to as the master cyclin because it is able to overcome deficiencies in other 
G1/S specific cyclins. Cyclin E also shows increased expression at the G1/S boundary. 
This increased expression is due in part to Cyclin Es ability to stimulate the transcription 
of additional cyclin E by disassociating from repression caused by p27Kip1.  Cyclin Es 
elevated expression coincides at a point where it is needed the most to promote S phase 
entry, and activate CDK2 (Möröy & Geisen, 2004).  
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CDK2 
 
 Cyclin dependent kinases (CDK) are a group of cell cycle related enzymes which 
are inactive until they are bound with their appropriate cyclin (Möröy & Geisen, 2004).  
When the appropriate cyclin protein binds the CDK, the CDK active site is exposed 
allowing phosphorylation of specific downstream targets.  In the case of histone gene 
regulation, the complex is comprised of cyclin E and its partner CDK2.  Looking further 
downstream in the pathway, the cyclin E/CDK2 complex plays a role in histone 
regulation by phosphorylating and activating p220NPAT, the next messenger in the process 
(as shown in green in Figure 4). 
p220NPAT 
 
 The identification of p220NPAT in 1996 represented a relatively new gene in cell 
cycle related research (Imai et al., 1996).  With the identification of p220NPAT researchers 
discovered that it binds to and is phosphorylated by the cyclin E/CDK2 complex (Zhao et 
al., 1998; Ma et al., 2000).  Though this establishes its upstream links, the connection of 
p220NPAT and histone gene regulation was made by observing that p220NPAT localizes to 
Cajal bodies, small nuclear organelles hypothesized to be the site where transcription and 
splicing complexes are assembled (Gall et al., 1999).  NPATs Cajal localization creates 
links to histone regulation because some Cajal bodies are physically linked to histone 
gene clusters.  Cajal bodies are also involved in the 3 processing which histone mRNAs 
must go though to be active (Frey & Matera, 1995; Abbott et al., 1999).  These 
observations, the physical link and 3 processing, strongly suggest that  p220NPAT is 
involved in cell cycle-dependent histone regulation.    
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The relationship between HiNF-P and  p200NPAT has only just begun to unfold. In 
vitro synthesized HiNF-P and p220NPAT co-immunoprecipitations show that detection of 
HiNF-P when precipitating p220NPAT (and vica versa) is easily achievable, proving a 
physical interaction of HiNF-P and p220NPAT.  To define the p220NPAT interaction region, 
deletion mutants of p220NPAT were created and show that three regions are necessary for 
interaction with HiNF-P.  These regions of p220NPAT are from amino acids 1-46, 121-145, 
and 208-318 (Miele et al., 2005).  In addition, the relationship of HiNF-P and p220NPAT 
in a functional manner was investigated.  Luciferase reporter constructs that had the 
HiNF-P H4 promoter binding site mutated were created, and this experiment showed a 
decrease in p220NPAT driven luciferase activity ( Zhao et al. 2000).  This data suggest a 
physical interaction between HiNF-p and p220NPAT.   
 To support these p220NPAT observations that p220NPAT is involved in cell cycle-
dependent histone regulation, Zhao et al (1998) demonstrated that (1) p220NPAT directly 
associates with histone gene clusters; and (2) that histone H2B and H4 transcription 
increases by overexpressing p220NPAT.  Ma et al. (1998) established (3) that p220NPAT is 
phosphorylated on CDK2 sites, and cyclin E is located at these foci; Lastly (4) mutating 
the CDK2 phosphorylation sites on p220NPAT causes a reduction in H2B reporter gene 
expression.  These results support the preliminary observations that p220NPAT is linked to 
histone gene regulation, but it is not the final regulatory step. 
 
HiNF-P 
 HiNF-P (orange box in Figure-4) is the final step in the cyclin E/CDK2/p220NPAT 
pathway regulating cell cycle dependent histone gene transcription.  p220NPAT requires 
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another messenger to enable histone transcription because it does not contain any known 
DNA binding motifs (Miele et al., 2005).  HiNF-P has been identified as a protein able to 
bind to the histone H4 gene promoter, and is necessary for histone H4 transcription 
(Mitra et al., 2003).  Because HiNF-P is associated with the H4 promoter, it is likely able 
to recruit p220NPAT.  Miele et al. (2005) demonstrate that p220NPAT requires HiNF-P to 
activate H4 by showing a decrease in p220NPAT dependent H4 promoter activity when 
HiNF-P is silenced by RNAi.  This experiment proves that HiNF-P is the final link in the 
signal cascade. 
 HiNF-P is part of a family of histone nuclear binding factors (HiNFs), which have 
been shown to bind to the H4 site II transcriptional regulatory element (Figure 3) (van 
Wijnen et al., 1991). Full length HiNF-P has a molecular weight of 65 kDa, and consists 
of 517 amino acids.  Figure 5 shows that HiNF-P contains 9 zinc fingers which are 
characteristic of one type of a  DNA binding protein (Alberts et al., 2002; Mitra et al., 
2003).  Database analysis revealed that HiNF-P is identical to MIZF, a protein identified 
to interact with MBD2, a methyl-CpG-binding protein (Mitra et al., 2003). Figure 5 also 
highlights in blue the HiNF-P specific conserved region (PSCR).  This region near the C-
terminus of HiNF-P is highly conserved throughout many species (Figure 6), thus this 
evolutionarily conserved region likely plays an important role in HiNF-P function (Mitra 
et al., 2003).  
 
Figure 5. HiNF-P Protein Schematic.  HiNF-P is a 517 amino acid protein and consists of nine zinc 
fingers (yellow), two acidic regions (green) and the PSCR (blue). 
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Figure 6. Amino Acid Alignment of the HiNF-P Specific Conserved Region (PSCR).  The PSCR, from 
aa S374 to R407, is highly conserved throughout many organisms. 
 
 HiNF-P is also a proven activator of histone H4.  Research has shown that 
overexpression of HiNF-P results in three fold enhancement of H4 promoter activity. The 
same result is not observed when the binding site on the promoter is mutated.  In an 
artificial construct with three copies of the HiNF-P binding site fused to a TATA box, a 
six to seven fold activation of H4 promoter activity was observed.  As a control to show 
HiNF-P specific activation, the large induction was not observed when the three binding 
sites were mutated so that HiNF-P could not bind (Mitra et al., 2003). 
 Over all, HiNF-P is required for efficient S phase progression.  The G1/S check 
point requires the presence of HiNF-P in order to move into S phase efficiently. HiNF-P 
deficient cells were generated, and their cell cycle progression was studied.  It was shown 
that HiNF-P-deficient cells do not cause a complete cell cycle block, but slow the cell 
cycle progression into S phase.  Even though HiNF-P expression levels were decreased in 
the cells, other compensatory transcription factors were likely present and carry on at 
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diminished levels (Mitra et al., 2003).  These data show a direct link between the 
presence of HiNF-P and the progression though the cell cycle. 
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Project Purpose 
 
 Previous research revealed that protein HiNF-P is responsive to the Cyclin 
E/CDK2/p220NPAT pathway, is the final link in replication dependent histone H4 
regulation, and is crucial for effective cell entry into S phase (Mitra et al., 2003; Miele et 
al., 2005).  In this report we wanted to closely examine what roles the HiNF-P specific 
conserved region (PSCR) plays in histone H4/n gene transcription. This 34 amino acid 
region (See Figure 6 from aa S374 to R407 ) is an area of high amino acid sequence 
homology, but its function is still unknown. We created 23 point and deletion mutants 
within or shortly following PSCR.  A deletion mutant encompassing the entire PSCR was 
also generated (See Figures 7 and 8 below).  By creating HiNF-P mutants with specific 
amino acids that were replaced, or that lacked specific portions, we were able to correlate 
changes in H4/n transcriptional activity with the location of the mutation. 
 All point mutations were changed to alanine residues, except one which was 
mutated to phenylalanine preserving the aromatic structure of the original amino acid.  
Both alanine and phenylalanine prevent any interactions that the original amino acid 
could have participated in.  Deletion mutations were selected because they systematically 
identified what spans of HiNF-P and the PSCR were involved in histone H4 regulation.  
Double mutations were also analyzed with both amino acids changed to alanine.   
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Figure 7.  Deletion mutants in HiNF-P. 
 
 
Figure 8.  Point and double mutations in HiNF-P. 
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 To answer our question we needed to observe both DNA binding activity and 
functional interactions of HiNF-P with H4/n.  We tested the HiNF-P mutants, to see if the 
mutations were able to bind the histone H4/n promoter (DNA binding activity) and to see 
if the mutations had an effect on the H4/n promoter (functional), using in vitro and in 
vivo approaches. The results identify the first twenty amino acids of the PSCR as a region 
that is highly likely to be important for HiNF-P DNA binding activity. 
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Materials and Methods 
 
Mutagenesis. Mutant oligonucleotides were designed following the instructions provided 
by Stratagenes QuickChangefi Site-Directed Mutagenesis Kit (cat. 200518).  
Oligonucleotides were obtained commercially or synthesized in house using a Beckman 
Oligo 1000M DNA synthesizer.    All oligonucleotides were gel purified by denaturing 
polyacrylamide gel electrophoresis.  Reactions were carried out following the 
manufacturers instructions using pFLAG-HiNF-P as a template.  Two clones of each 
mutant construct were selected.  All final HiNF-P mutant constructs were confirmed by 
full length sequencing. The oligonucleotides used to generate the mutants are listed in the 
table below. 
 
Name 5' Sequence 3' 
S374A CAAGTGGCCCGCAGGGCATCCCC 
∆PSCR GTTCAAGTGGCCCCAACCACAAGAGG 
∆PSCRa GTTCAAGTGGCCCGAACATGAAGATGGC 
∆PSCRb CCCGTTTTCGGTACAAGGTTCGCTACG 
∆PSCRc GCTGCAGCTGCTGACACAGCAACTG 
∆PSCRd CTACGAGAGTGTAGAGCAACCACAAGAGG 
Y381F CATCCCCGTTTTCGGTTCAAGGAACATGAAGATGG 
Y381A GGCATCCCCGTTTTCGGGCAAAGGAACATGAAGATGGCT 
Y388A AAGGAACATGAAGATGGCGCAATGCGGCTGCAGCTGG 
Y396A CTGCAGCTGGTTCGCGCAGAGAGTGTAGAGCTGAC 
S398A GCTGGTTCGCTACGAGGCAGTAGAGCTGACACAGC 
T402A CGAGAGTGTAGAGCTGGCACAGCAACTGC 
S418A GGCCTGGGAACGGCCCTGAACGAGAGC 
S456A CCCTCTCAGCCGCTCAGGACAACCC 
Y396A/S398A* CAGCTGGTTCGCGCCGAGGCAGTAGAGC 
T402A/Y396A** GAGTGTAGAGCTGGCACAGCAACTGCTGCGG 
T402A/Y398A*** GGCAGTAGAGCTGGCACAGCAACTGCTG  
 
 
Table 1.  Mutant oligonucleotides used to create HiNF-P mutants. The underlines indicate what 
nucleotides were changed, bold font indicates where the deletion is located. * Backbone template was 
pFLAG-S398A-HiNF-P, ** Backbone template was pFLAG-S396A-HiNF-P.  ***Backbone template was 
pFLAG-Y398A-HiNF-P 
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Transient Transfections.  Cells were seeded so on the day of transfection they were 40-
50% confluent. Twenty-four hours later, cells were washed with room temperature PBS, 
and complete media warmed to 37°C was added.   Transfection was achieved using a 
ratio of 1 µg of DNA: 3 µl of transfection reagent FuGENE6 (Roche) in incomplete  
media.  The DNA/FuGENE6/media mix was vortexed gently and allowed to incubate for 
15 minutes at room temperature.  The mixture was added drop-wise to the cells.  Plates 
were gently swirled afterwards.   
 
Nuclear Extract Preparation. HeLa cells were seeded at 0.5 x 106 and twenty-four 
hours later transfected with the indicated plasmids (4 ug per 100 mm plates of each 
construct; see above for transfection methods using FuGENE6). Twenty-four hours after 
transfection, cells were washed with ice cold PBS and transferred to a tube where they 
were centrifuged at 1,000g for 5 minutes at 4 °C in an Eppendorf Centrifuge 5415R.  All 
subsequent procedures were done at 4°C, and centrifuged in the Eppendorf Centrifuge 
5415R .  The supernatant was carefully aspirated, and the pellet was suspended in cold 
NP-40 lysis buffer (10mM Tris-HCl (pH 7.4), 3mM MgCl2, 10mM NaCl, 0.5% NP-40) 
by pipetting gently up and down until the mixture was homogenous.  The sample was left 
on ice to incubate for 10 minutes, and then spun at full speed for 30 seconds.  The 
supernatant was removed, and the pellet was re-suspended by pipetting in 400ul of cold 
Hypotonic Buffer (10mM Hepes (pH 7.9), 1.5 mM MgCl2, 10 mM KCl).  Samples were 
spun in the same centrifuge at 4,500g for 1 minute, supernatant removed, and 100 ul of 
cold Extraction buffer (20 mM Hepes (pH 7.9), 1.5 mM MgCl2, 420 mM KCl, 0.2mM 
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EDTA, 20% glycerol) was added.  Samples were left to rock in cold room for 45 minutes.  
After rocking, samples were spun at full speed for 5 minutes, the supernatant containing 
the nuclear extracts was harvested and quickly frozen in liquid nitrogen and kept at -80° 
C until use. 
 
In vitro transcription and translation.  Proteins were synthesized using Promegas 
TNT T3 Quick Coupled Transcription/Translation System (cat. L1170), following the 
provided protocol. The integrity of IVTT produced proteins was checked by western 
blots. 
 
Immunofluorescence microscopy. All procedures were done at 4°C, unless otherwise 
noted.  SaOS cells were plated at 0.08 x 106 cells per well in a six-well plate (Corning), 
onto dried coverslips coated in 0.5% Difco TM Gelatin (BD Sciences).  Cells were taken 
24 hours after transfection with 0.5 ug of each construct (as described above) on ice and 
washed twice with ice cold PBS.  Whole cell fixative ( 2 mL; 3.7% formaldehyde in PBS) 
was added to each well, for 10 minutes.  Wells were aspirated, and washed once with ice 
cold PBS.  Permeabilizing solution (1 mL; 0.25% Triton X-100 in PBS) was added to 
each well for 20 minutes.  Wells were aspirated, and 1 mL of PBSA (0.5% Bovine serum 
albumin in PBS) was added to each well.  The lids of each six well plate were covered 
with Parafilm, and a  drop of the primary antibody (20 ul; Sigma M2 Mouse α FLAG 
1:4,000 in PBSA) was added on the Parafilm.  Coverslips were placed cell side down on 
the antibody drop, and incubated at 37 °C in the dark for 1 hour.  Coverslips were placed 
back in their respective wells facing upwards, and washed four times with ice cold PBSA.  
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Secondary antibody (20 ul; Alexa 488 Goat α Mouse 1:800 in PBSA) was added to a 
new strip of Parafilm in the exact same way as primary, and incubated at 37 °C in the 
dark for 1 hour. Coverslips were placed back in their respective wells facing upwards, 
and washed four times with ice cold PBSA.  Cells were DAPI stained (0.5ug/mL DAPI in 
0.1% TritonX 100-PBS) for 5 minuets on ice. Cells were washed once in 0.1% TritonX-
100/PBS, then twice with ice cold PBS.  Coverslips were immediately mounted using 
ProLong Gold antifade reagent (Invitrogen), and sealed.  Slides were stored at -20°C.  
 
Western Blots.  Samples were prepared by mixing with gel loading buffer (final 
concentration 50 mM Tris-Cl pH6.8, 100 mM DTT, 2% SDS, 0.2% Bromophenol blue, 
and 10% glycerol), and boiling for 5 minutes.  Prepared samples and molecular weight 
marker (Bio-Rad cat. 161-0374) were electrophoresed on an SDS-10% or 4-15% gradient 
gel (Bio-Rad) and blotted onto a polyvinylidene difluoride Immobilon-P membrane 
(Millipore).  Immunodetection was performed using primary antibodies directed against 
mouse monoclonal or rabbit polyclonal FLAG (1:4,000 to 1:8,000), mouse monoclonal 
FLAG-HRP (1:5,000), or rabbit polyclonal HiNF-P (1:5,000). Western Lightning 
Chemiluminescence Reagent Plus (Perkin Elmer Life Sciences) was used to detect the 
signal.   
 
Electrophoretic Mobility Shift Assays (EMSAs) were preformed incubating the probe 
(20 fmol of labeled site II H4/n probe with at least 20,000cpm), and a constant total 
amount of protein (IVTT: 1-2ul; NuE: 2-5ug) in Buffer C (50 mM KCl, 10% glycerol 
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0.1 ug/ul salmon sperm DNA used as a non specific competitor, 1 mM DTT, 0.5 mM 
MgCl2,  and 0.1 mM ZnCl2 ) for twenty minutes at room temperature.  All competitors 
(See Table 2 for sequence) were added in 100X molar excess, for reactions with no 
competitors water was added to keep the total volume the same.  Samples were run on a 
non denaturing polyacrylamide gel, and when finished they were vacuum dried at 80°C 
to filter paper, and exposed to a Kodak BioMax XAR or MR X-ray film.  Film was 
exposed to the gels at -80°C for varying lengths, allowed to warm to room temperature, 
and then developed. 
Competitor 5'- Sequence- 3' 
Specific  CTTCAGGTTTTCAATCTGGTCCGATACT 
HiNF-P mutant  CT CAGGTTTTCAATCTTCTACGATACT 
Non specific SP1 ATTCGATCGGGGCGGGGCGAGC 
Table 2.  EMSA competitor sequences.  Specific competitor sequence was derived from the Site II HiNF-
P binding site. Underlines indicate deviation from consensus sequence. 
 
Luciferase Assay. Luciferase assays were carried out using Promegas Dual-Luciferasefi 
Reporter Assay System (cat. E1960). U2-OS cells were seeded at 0.13 x 106 cells per 
well in six-well plates.  24 hours later cells were washed with room temperature PBS, and 
2 mL/well complete McCoys media warmed to 37°C was added.   DNAs used per well 
were: 200 ng of the reporter p3x site II/Luc construct, 5 ng of phRL-null (Promega) to 
normalize for transfection efficiency, 200 ng of p220NPAT and variable amounts of wild 
type or mutant HiNF-P. After 24 hours, transfected U2-0S cells (see transfection methods 
above) were incubated with 250 ul/well of 1x Passive Lysis Buffer for 15 minutes at 
room temperature.  Plates were gently swirled during the incubation on an orbital shaker.  
After incubation, 20 ul of each well was sampled in a 96-well COSTAR Assay Plate and 
the relative light unit  was determined using the Dual Luciferase Reporter Assay System 
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in a Glomax luminometer (Promega).  Firefly luciferase values were normalized to 
Renilla luciferase, and then values adjusted with the empty vector being equal to 1.  
Lysate samples were prepared for western blot by spinning samples for 5 minutes at full 
speed at 4 °C, and mixing 12 ul with 6 ul of 3X PAGE gel loading buffer (as described 
above). 
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Results 
 
 To ensure that mutations introduced into HiNF-P did not have an effect on the 
subcellular localization, SaOS cells were transfected with WT or mutant HiNF-P, and 
harvested for whole cell immunofluorescence microscopy.  In Figure 9 images are 
presented showing that wild type and all types of mutant HiNF-P (green) are localized 
exclusively in the nucleus (blue).  The phase image shows that the cell has the correct 
morphology and is a healthy cell.  Two mutants displayed slightly higher HiNF-P 
staining in the cytoplasm (HiNF-P 312-517 (∆N3), and HiNF-P mutant S398A), but the 
majority of the staining was nuclear.  It is possible that this small cytoplasmic expression 
was caused by the over-expression of mutant HiNF-P.  Though only one image is 
displayed for each mutant, the image selected is a representative photograph of all the 
cells viewed on the slide. 
Previous studies have used Electrophoretic Mobility Shift Assays (EMSAs) to 
check the ability of the HiNF-P to bind DNA (van Wijnen, et al., 1992; Mitra et al. 2003).  
These highly sensitive assays allow quantification of binding ability, relative to wild type 
binding activity.  We analyzed the DNA binding activity of HiNF-P mutants with a 
histone H4/n DNA probe, using both HiNF-P from Nuclear Extracts (NuE) and from an 
In Vitro Transcription and Translation (IVTT) kit. In Figure 10 the DNA binding 
activities of the HiNF-P point mutations are presented.  Panel A indicates an interaction 
of nuclear extracted wild type and mutant HiNF-P, with 32P-γ-ATP labeled histone H4/n 
probe.  Mutants with an observed decrease in binding activity are Y381A, Y388A, and 
S398A/T402A. Mutants with an observed increased binding activity are Y396A and 
S398A.  One mutant, Y381A, displayed no specific band.  To ensure that the mutations 
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truly had no DNA binding activity, films were exposed for extended periods of time (i.e.  
several over-night exposures).  Even after the prolonged exposures, no specific band was 
detected (data not shown).  This result indicates that the mutant has no binding activity. 
In Figure 10 Panel B, the expression of each mutant protein shown.  These data suggest 
that the mutation is not lethal, and that the protein is expressed at similar levels as the 
wild type so the DNA binding activity can also be compared to wild type DNA binding.   
 
 
Figure 9a.  SaOS immunofluorescence. Wild type HiNF-P shows a nuclear subcellular localization, and 
all mutations demonstrate that the nuclear localization signal is unaffected. Phase: 200ms; DAPI stain (blue) 
for DNA 50ms; FITC (green) for HiNF-P 500ms.  Panel a presents three negative controls, and wild type.  
Panels b and c present the experimental mutants.  Note: N-terms subcellular localization was determined 
to be nuclear by previous work (not shown). 
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Figure 9b.  Imunofluoresence continued. 
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Figure 9c. Immunofluorescence continued. 
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Figure 10. DNA binding activity of mutant HiNF-P as determined by EMSA using HeLa nuclear 
extracts.  (A) Panel A shows two bands, with the specific band indicated by the arrow.  The figure is 
arranged in a way that removes lanes which do not pertain to this report.  In order to rank the DNA binding 
ability of each mutant, each band was compared to the wild type band run from the same experiment.  The 
wild type bands (lanes 3, 7, 13, 17) correspond to the samples that follow immediately to their right until 
the next wild type band.  Free probe is indicated by the double headed arrow.  (B)  Panel B shows a 
Western blot, demonstrating that the mutant proteins are being expressed at the expected size, and at 
similar levels to wild type.   
 
 The DNA binding ability of the HiNF-P deletion mutations is shown in Figure 11.  
The EMSAs in Panel A show increased binding in HiNF-P 1-452, and HiNF-P 1-395.  A 
complete lack of DNA binding ability is observed for the HiNF-P 1-372 (N-term), HiNF-
P 373-517 (C-term), HiNF-P 230-517 (∆N2), HiNF-P 312-517 (∆N3), ∆PSCR, ∆PSCRa, 
and ∆PSCRb deletions.  All other mutants have similar binding ability as wild type 
HiNF-P.  Protein expression levels were also checked by Western blot, and the results are 
shown in Panel B.  Increased HiNF-P expression was observed for HiNF-P 1-395, 
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∆PSCRd, HiNF-P 312-517 (∆N3),  HiNF-P 1-452, and the HiNF-P 1-372 (N-term) 
deletions.  Decreased expression was noticed for ∆PSCR, while the HiNF-P 373-517 (C-
term) had no expression at all, which could be caused by a decrease of the protein half 
life.  Future experiments should assay the half life of each mutant protein to determine if 
it is different from the wild type.     
 
Figure 11. DNA binding activity of HiNF-P deletion mutants as determined by EMSA using HeLa 
nuclear extracts. (A) Panel A shows two bands, with the HiNF-P specific bands indicated by the single 
arrowhead arrow on the far left.  Lower arrows also point out the specific bands that run faster in the gel 
because of the truncated protein.  The figure is arranged in a way that removes lanes which do not pertain 
to this report.  In order to rank the DNA binding ability of each mutant, each band was compared to the 
wild type band run from the same experiment.  The wild type bands (lanes 2, 9, 11, 14, 17) are used to 
compare the samples that follow immediately to their right until the next wild type band.   Free probe is 
indicated by the double arrow head. (B)  Panel B shows a Western blot, demonstrating that the mutant 
proteins are being expressed correctly with the expected size, and at similar levels to wild type.  
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 Mutant HiNF-P created by using an IVTT kit was also assayed for DNA binding 
activity.  By synthesizing the protein in vitro HiNF-P was assayed without the effects of 
post translational modifications or interacting proteins.  Any effect observed was due 
solely to the presence of HiNF-P.  Figure 12 displays these results.  In Panel A, S456A 
was observed to have decreased binding, while T402A had next to no activity at all, and 
Y381A did not display any binding activity.  An increase in DNA binding ability was 
observed in S418A, Y396A, and S398A.  The Western blot in Panel B shows that all of 
HiNF-P mutants are expressing.  
 
Figure 12. DNA binding activity of IVTT produced mutant HiNF-P as determined by EMSA.   (A) 
Panel A displays the EMSAs, and the HiNF-P specific band is marked by the single arrowhead. The figure 
is arranged in a way that removes lanes which do not pertain to this report.  In order to rank the DNA 
binding ability of each mutant, each band was compared to the wild type band produced from the same 
experiment.  The wild type bands (lanes 3, 8, 16, 18) are used to compare against the samples that follow 
immediately to their right until the next wild type band.  Free probe is indicated by the double arrow head. 
(B)  Panel B shows a Western blot, demonstrating that the IVTT produced mutant proteins are being 
expressed correctly.  
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 The deletion mutants produced by IVTT were also assayed in a similar manner 
(Figure 13). Panel A shows a decrease in HiNF-P 1-395, and HiNF-P 1-452.  The HiNF-
P 1-372 (N-term), HiNF-P 373-517 (C-term), HiNF-P 230-517 (∆N2), HiNF-P 312-517 
(∆N3), ∆PSCR, ∆PSCRa, and ∆PSCRb mutations were observed to have no DNA 
binding activity. In Panel B expression was checked by Western blot.  In lane 3 of Panel 
B an arrow indicates the specific band of HiNF-P 1-395, which is hiding close to the non 
specific band (identified in the mock lane, and present in the wt lane) mimicking a 
doublet. All mutant proteins were shown to be expressing, except HiNF-P 373-517 (C-
term). 
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Figure 13. DNA binding activity of IVTT produced HiNF-P deletion mutants as determined by 
EMSA.  (A) Panel A displays the wild type HiNF-P specific band with a feathered arrow, and solid arrows 
indicate mutant HiNF-P specific bands that migrate faster in the gel because of the deletion.  The figure is 
arranged in a way that removes lanes which do not pertain to this report.  In order to rank the DNA binding 
ability of each mutant, each band was compared to the wild type band run from the same experiment.  The 
wild type bands (lanes 3, 10 , 16) are used to compare the samples that follow immediately to their right 
until the next wild type band.  Free probe is shown with a double headed arrow. (B)  Panel B shows a 
Western blot, demonstrating that the IVTT produced mutant proteins are being expressed correctly. A 
feathered arrow points out the wild type band, and a black arrow points out the specific band of deletion 
mutants that migrate lower in the gel. 
  
In addition to assaying DNA binding activity, this report also addressed the 
functional activity of mutant HiNF-P by assaying the effects of the HiNF-P protein on the 
expression on a multimerized site II promoter driving a luciferase reporter.  Figure 14 
shows a dose curve in response to increasing amounts of wild type or mutant HiNF-P, as 
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measured by the luciferase assay.  Figure 15 shows the specificity of the reaction by 
assaying increasing amounts of mutant HiNF-P with a luciferase construct that has Site II 
(HiNF-P binding domain) mutated.  The dosage in both experiments was confirmed by 
Western blot shown in Figure 16.  All but one lane fits the trend of increasing HiNF-P 
expression.  The abnormal lane, ∆PSCRb-1, has lower than expected luciferase activity at 
the 25 ng level.  Figure 16 shows that corresponding expression levels are less than all of 
the other 25 ng conditions.  This low expression, coupled with low luciferase activity 
suggests an error in the transfection, and that the actual value would be slightly higher.  
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
From Mitra et al. (2003) 

 
Figure 14.  Luciferase activity in response to increasing doses of HiNF-P. (A) Figure of the reporter 
complex used in the assay.  Three site II HiNF-P-binding sites are located upstream of a TATA box, 
driving a luciferase reporter.  (B) This experiment is a composite of two experiments carried out strictly 
under the same conditions.  All values were normalized against renilla then normalized again with empty 
vector set as 1.  p3X site II HiNF-P H4n/Luc was used as the reporter.   Total amount of DNA was kept 
constant.  Bars 3 through 6 do not contain p220NPAT while lanes 2, and 7 - 30 contain 200ng of p220NPAT.   
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From Mitra et al. ( 2003) 
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Figure 15.  Luciferase activity using the p3X site II HiNF-P mut. H4n/Luc construct. (A) Figure of the 
reporter complex used in the assay.  Three mutated site II HiNF-P-binding sites are located upstream of a 
TATA box.  These multimerized mutated sites do not bind HiNF-P so the luciferase reporter is not 
activated. (B)  Increasing expression of HiNF-P does not bind to mutant site II.  This control shows that it 
is HiNF-P expression that is driving the luciferase reporter, and preventing HiNF-P binding reduces 
luciferase activity. All values were normalized against renilla then normalized again with empty vector set 
as 1.  Total amount of DNA was kept constant.   
 
 38 
 
Figure 16.  Western blot from luciferase assay lysate shows an increasing amount of HiNF-P expression 
corresponding with the an increasing amount of transfected plasmid DNA (25ng, 50ng, 100ng, 200ng).  
The last four lanes of the bottom figure are the samples that were used in the negative control in figure 9.  
CDK2 was used as a loading control in all samples. 
 
Because of the high levels of overexpressed HiNF-P, the results of a dose curve 
could be the results of squelching and not a true representation.  To account for this the 
lowest level of mutant HiNF-P construct transfected was plotted separately below in 
Figure 17.  This figure shows that mutants that have no DNA binding activity have 3 to 6 
times lower luciferase activity than those which are able to bind DNA. 
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Figure 17.  Luciferase activity of the lowest range of transfected HiNF-P constructs suggests that 
mutants that can not bind DNA (observed by EMSA) have lower luciferase activity than mutants that do 
bind DNA.  p3X site II HiNF-P WT H4n/Luc was used as a reporter and all values were normalized against 
renilla then normalized again with empty vector set as 1.  Total amount of DNA was kept constant.   
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Discussion 
 
To investigate the role the HiNF-P specific conserved region (PSCR) plays in the 
biological activity of HiNF-P, an extensive mutagenesis project was carried out.  Point, 
double, and deletion mutations were generated and assayed to investigate their DNA 
binding activity and their ability to activate the histone H4/n promoter.  All point 
mutations were within the defined regions of the PSCR, but two additional point mutants 
were selected based on their proximity to an acidic region (E339 to E344). Because the 
PSCR has such a conserved amino acid sequence (Figure 6), it was hypothesized that its 
function is crucial to HiNF-P.  The results presented in this report suggest that the PSCR 
plays an essential role in DNA binding, and more specifically that a span of the first 
twenty amino acids of the PSCR (S374- L393) are essential. 
Table 3, below, gives a summary of all 23 mutant proteins that were analyzed in 
this report in regards to DNA binding and protein expression levels.  Throughout the 
duration of this report, successful expression of  HiNF-P 373-517 (C-term) was never 
achieved, which is consistent with previous work conducted in the lab (R. Medina, P. 
Mitra, personal communication).  It is possible that HiNF-P 373-517 (C-term) is not 
stable enough on its own.  This lack of stability would explain the absence of signal in 
both the immunofluorescence microscopy and in western blots, and in both EMSAs 
because the protein was not being expressed.   
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The immunofluorescence data in Figure 9 demonstrate that most mutations did 
not affect the nuclear localization signal.  While S398A and HiNF-P 312-517 (∆N3) had 
a higher FITC signal (stain for HiNF-P protein) compared to WT samples, it is possible 
that overexpressed HiNF-P is being sent into the cytoplasm.  The bulk of the 
immunofluorescence data suggest that the nuclear localization signal is not located with 
in the PSCR. 
An interesting finding in this project was the difference in the DNA binding 
ability of some HiNF-P mutants when overexpressed in cells and assayed in nuclear 
extracts compared to IVTT produced proteins.  In mutants HiNF-P 1-395, HiNF-P 1-452, 
and HiNF-P T402A there was a decrease in binding activity when the protein was 
synthesized in vitro compared to when it was overexpressed in vivo.   The most 
pronounced effect was observed for the HiNF-P mutants 1-395 and T402A. Similar 
results were observed in HiNF-P S418A, but this mutant had increased binding activity 
when synthesized in vitro.  These observations suggest that these specific residues, or 
amino acids encompassed by the deletion, undergo posttranslational modifications which 
are not available in the in vitro system. Another interesting possibility, that applies to in 
vivo and in vitro synthesized protein, is that the mutations are changing HiNF-P protein 
structure, and therefore its ability to bind DNA is compromised. 
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Table 3.  Interaction of HiNF-P mutants based on Western blot and EMSA data. * Indicates that this 
data was observed in previous work (not shown).   
 
HiNF-P mutant Y381A stood out as the only tyrosine mutant that had no binding 
activity when the tyrosine (Tyr) was mutated to alanine.  Because of this, Y381 was 
selected to be mutated to phenylalanine (Phe), and assayed with the rest of the mutants.  
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The Phe substitution created a functional mutant that mimics the bulky structure of the 
original residue, causing fewer structural deviations from wild type HiNF-P. This also 
allowed a differentiation to be made between a structural phenomenon and a 
phosphorylation modification, because the only difference between Tyr and Phe is the 
hydroxyl group in Tyr which is able to be phosphorylated.  
We observed that the binding activity of mutants Y381A and Y381F were 
drastically different.  While mutant HiNF-P Y381A shows a complete lack of DNA 
binding activity, HiNF-P mutant Y381F had near wild type DNA binding.   This 
observation allowed us to rule out the possibility that lack of DNA binding activity of 
mutant Y381A is due to absence of in vivo phosphorylation of Y381, but is most likely 
due to a structural change produced by this mutation. 
We suggest that a structural change also caused increased binding of HiNF-P 
mutant Y396A.  This mutant had identical EMSA results using nuclear extracts and IVTT 
produced protein, both showing increased DNA binding relative to wild type HiNF-P.  
Because this effect is observed in vivo and in vitro, post translational modifications were 
ruled out.  The likely cause is that the mutation results in a structural change, allowing 
mutant HiNF-P to bind to the site II element in the H4/n promoter with greater affinity. 
The luciferase assays demonstrate the ability of a mutant both to bind DNA and to 
activate transcription.  These assays proved to be a large challenge in both 
implementation and later, interpretation. Figure 14 is a composite of two experiments, 
strictly carried out under the exact same conditions.  It shows that p220NPAT is required 
for H4/n activation, and together HiNF-P and p220NPAT produce a synergistic effect as 
shown by Mitra et al.  (2003).   
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Though the initial data are in agreement, the trend observed by the luciferase 
assay when increasing the transfection dose of HiNF-P does not follow the current HiNF-
P model.  As mentioned in the discussion, HiNF-P does not act alone but acts as a 
complex with at least one (p220NPAT) if not more co-factors.  When expressing excess 
amounts of HiNF-P well above wild type levels it is possible that the excess HiNF-P may 
be binding these co-factors, leaving little for the HiNF-P that activates H4/n.  This 
squelching effect would prevent accurate results because with increasing HiNF-P 
expression a decrease in the amount of co-factors available to bind with potentially 
biologically active HiNF-P would also follow.  We believe this trend observed in Figure 
14 to be artificial, and the product of squelching causing non specific luciferase activity. 
When working out the conditions to determine how much HiNF-P plasmid to 
transfect, 25 ng was selected based on its high luciferase activity values.  In retrospect, 
and in light of recent data (not shown), an amount closer to 5 ng would have provided 
more accurate results since this level of transfection mimics HiNF-P endogenous protein 
expression levels.  Further studies investigating the functional activity of HiNF-P should 
use this lower dose.  Because of the concern that increasing amounts of HiNF-P are 
causing squelching, analyzing only the lanes transfected with 25 ng (Figure 17) allows 
for interpretation that follows the EMSA data.  Figure 17 illustrates that both binding and 
non-binding mutants activate the promoter less than wild type and p220NPAT together.  
More importantly, Figure 17 shows that mutants unable to bind DNA have a 3-6 fold 
decrease in luciferase activity compared to those that do bind DNA.  These results 
suggest that the PSCR is essential for DNA binding. 
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  Previous work has shown that p220NPAT interacts with the C-terminus of HiNF-P  
between amino acids 373 and 517 (Miele, et al., 2005).  This region spans the PSCR, but 
also encompasses many other residues.  It is possible that some mutants affect NPAT 
binding, and consequently affect HiNF-Ps ability to bind DNA and activate transcription.  
Future studies should define the NPAT binding site(s) on HiNF-P to rule out disrupting 
the interaction of HiNF-P and p220 NPAT.   
The HiNF-P Specific Conserved Region (PSCR) shown in Figure 5 contains a 
highly conserved amino acid sequence, that likely has a vital role in HiNF-P function.  
The results of the DNA binding assay suggest that residues in the first twenty amino 
acids are important in DNA binding.  Both in vivo (Figure 11) and in vitro (Figure 13) 
EMSAs show that the deletion of the entire ∆PSCR, ∆PSCRa, or ∆PSCRb cause a loss of 
DNA binding activity.  This is further supported by Figure 17 where a substantial 
decrease in luciferase activity is observed for the same mutants, when compared to wild 
type HiNF-P.  To see what individual residues participate in DNA binding, future 
research should make point mutants of the twenty amino acids in PSCRa, and PSCRb.  
This will allow more specific identification of the amino acids that bind and activate H4/n. 
The HiNF-P specific conserved region is an area of much interest, because of the 
high degree of sequence homology throughout many species. In this MQP study, regions 
of the PSCR were mutated to evaluate the HiNF-Ps ability to bind DNA.  Experimental 
observations were made exploring the DNA binding and functional changes induced by 
the mutations.  The mutations caused changes in HiNF-Ps ability to bind to DNA and 
activate histone H4/n promoter.  The data in this report suggest that the first twenty 
amino acids of the PSCR are essential for DNA binding. 
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